GLP-1 receptor agonists—including Ozempic®, Mounjaro®, Semaglutide, and Tirzepatide—have been prescribed (on-and-off label) for weight management, including obesity, along with a reduced caloric diet and increased physical activity. Ozempic® and Mounjaro® are FDA-approved for type 2 diabetes treatment, but may be prescribed off-label for weight loss at a healthcare provider’s discretion. Take precaution with, and read all warnings concerning, GLP-1s, as they may cause serious side effects, including a risk of thyroid c-cell tumors. Do not use if you or your family have a history of a type of thyroid cancer called MTC (medullary thyroid carcinoma) or MEN 2 (multiple endocrine neoplasia syndrome). See important warnings & safety info about these medications. As an alternative to FDA-approved branded products, where appropriate, a provider may prescribe a GLP-1 compounded drug that is effective when prescribed off label for weight loss, which is prepared by a state-licensed sterile compounding pharmacy partner. Although GLP-1 compounded drugs are permitted to be prescribed under federal law, they are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review. Thoroughly review all warnings and essential safety information regarding these drugs. See important safety information.
You’ll provide physical stats, medical history, and prescription preferences
If you meet qualifications, you’ll receive an Rx or schedule a virtual consultation
That’s it! Watch the weight fall off, and easily renew online when it’s time
GLP-1 Rx drug products require an assessment from a licensed healthcare provider who will determine if the medication is appropriate. Your clinician will make a treatment decision based on your medical history and overall health after the completion of a telehealth consultation. GLP-1 receptor agonists—including Ozempic®, Mounjaro®, Semaglutide, and Tirzepatide—have been prescribed (on-and-off label) for weight management, including obesity, along with a reduced caloric diet and increased physical activity. Ozempic® and Mounjaro® are FDA-approved for type 2 diabetes treatment, but may be prescribed off-label for weight loss at a healthcare provider’s discretion. Take precaution with, and read all warnings concerning, GLP-1s, as they may cause serious side effects, including a risk of thyroid c-cell tumors. Do not use if you or your family have a history of a type of thyroid cancer called MTC (medullary thyroid carcinoma) or MEN 2 (multiple endocrine neoplasia syndrome). See important warnings & safety info about these medications. As an alternative to FDA-approved branded products, where appropriate, a provider may prescribe a GLP-1 compounded drug that is effective when prescribed off label for weight loss, which is prepared by a state-licensed sterile compounding pharmacy partner. Although GLP-1 compounded drugs are permitted to be prescribed under federal law, they are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review. Thoroughly review all warnings and essential safety information regarding these drugs.See important safety information.
As the weight comes off, it’s easier to do more physical activities and I’ve gained my energy back. Mentally, this has completely changed my life.
Caitlin Walsh
The Vitamin Shoppe Field Training Manager
I feel great! This is a big motivator in helping me move more and make better food decisions. My daily walks are getting easier—and farther.
Journey Armstrong
The Vitamin Shoppe District Sales Manager
Learn the science behind these similar but different GLP-1 medications to fully understand your options.
Check It Out >Lindsey Boggs struggled with her weight since childhood, until her doctor recommended a treatment that would change everything.*
Check It Out >*Research suggests Mounjaro (tirzepatide) can lead to an average weight loss of 20–25% over a year when combined with a healthy lifestyle. Weight loss can vary depending on a patient’s response to the medication and ability to make lifestyle changes.
It’s vital to stay on top of your nutrient intake, digestive health, and gut microbiome while taking GLP-1s. This nutritionist-approved assortment of multis, protein, probiotics, fiber, and more is designed to support whole-body wellness alongside your medical weight-loss journey.
SHOP NOWIt’s vital to stay on top of your nutrient intake, digestive health, and gut microbiome while taking GLP-1s. This nutritionist-approved assortment is designed to support whole-body wellness along your weight-management journey.
Our team of advisors is here to empower patients to take control of their wellness journeys by combining medical, dietary, and healthy lifestyle expertise.
Prescription products require an online medical assessment and consultation with a healthcare provider who will determine if a prescription is appropriate. The Vitamin Shoppe will match you with an independent licensed physician who will evaluate whether or not you are an appropriate candidate for any prescription products. If appropriate, the physician may write you a prescription for the product that can be picked up at your local pharmacy.
The information provided on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you have any questions or concerns about your health, please talk to a doctor. The Vitamin Shoppe is not offering advice, recommending or endorsing any specific prescription drug, pharmacy, or other information on the site. The Vitamin Shoppe provides no warranty for any information. Please seek medical advice before starting, changing, or terminating any medical treatment. The independent licensed healthcare provider through our virtual healthcare platform can conduct an initial evaluation of your symptoms but may need to refer you to a specialist or for in-person treatment. If you are experiencing life-threatening symptoms, seek emergency medical attention immediately.
The Vitamin Shoppe is not sponsored by or affiliated with any of the third-party brands identified. Trademarks, brands, logos, and copyrights are the property of their respective owners. Ozempic® is registered trademarks of Novo Nordisk A/S. Mounjaro® and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Compounded medications are made in State Board of Pharmacy-licensed sterile compounding pharmacies, or FDA-licensed 503(b) Outsourcing Facilities. While these facilities are strictly regulated, the compounded medications they make are not FDA-approved, as they are compounded based on an individual provider’s prescription for a specified patient. Strength, dose, route of administration, and other variables may make compounded medications different from FDA-approved drugs which makes directly comparing results & risk profiles between FDA-approved drugs and compounded drugs difficult. Any compounded drugs prescribed are based on a licensed provider’s medical judgment based on a telehealth encounter and medical history.
Powered by